1. Asao T, Shibata HR, Batist G, Brodt P (1992) Eradication of hepatic metastases of carcinoma H-59 by combination chemoimmunotherapy with liposomal muramyl tripeptide, 5-fluoroouracil, and leucovorin. Cancer Res 52:6254
2. Barna BP, Chou SM, Jacobs B, Yen-Lieberman B, Ransohoff RM (1989) Interferon-? impairs induction of HLA-DR antigen expression in cultured adult human astrocytes. J Neuroimmunol 23:45
3. Barna BP, Eppstein DA, Thomassen MJ, Nestor JJ Jr, Ho T, Medendorp SV, Deodhar SD (1993) Therapeutic effects of a synthetic peptide of C-reactive protein in pre-clinical tumor models. Cancer Immunol Immunother 36:171
4. Creaven PJ, Cowens JW, Brenner DE, Dadey BM, Han T, Huben R, Karakousis C, Frost H, LeSher D, Hanagan J, Andrejcio K, Cushman MK (1990) Initial clinical trial of the macrophage activator muramyl tripeptide-phosphatidylethanolamine encapsulatin liposomes in patients with advanced cancer. J Biol Response Mod 9:492
5. Deodhar SD, James K, Chiang T, Edinger M, Barna BP (1982) Inhibition of lung metastases in mice bearing a malignant fibrosarcoma by treatment with liposomes containing human C-reactive protein. Cancer Res 42:5084